A new trial has shown for the first time that a combination of three targeted therapies can improve survival in patients with advanced colorectal cancer with a specific mutation. The three-drug ...

Publisher Ubisoft is making no secret of its plans to utilise generative AI tech — at least, it certainly sounds that way in new comments from CEO Yves Guillemot. The controversial technology has been ...